Attending the summit of the Glut1 Deficiency Foundation 2017 to talk about METAglut1™ our innovative IVD blood test
July 13, 2017
€3.2M Grant awarded: major boost for the launch of our validation study
June 11, 2018
April 27, 2018
[EVENTS] Company ; METAglut1™
We had the honor of exhibiting at the 46th Annual Meeting of the Société Européenne de Neurologie Pédiatrique (SENP+), a key event dedicated to advancing the field of pediatric neurology in Europe.
This gathering, happening in Barcelona, brought together leading experts and practitioners in pediatric neurology to discuss the latest research and advancements in the field.
We had the opportunity to welcome discussions on our booth about METAglut1™, our rapid innovative IVD blood test, designed to aid the early diagnosis of GLUT1DS.
Glut1 Deficiency Syndrom (Glut1DS), also known as De Vivo Disease, is a rare neuro metabolic disorder that can significantly impact the lives of affected children.
We believe that our diagnostic tool represents a significant advancement in identifying the condition, which can have profound implications for affected individuals and their families.
About the event organizer
The Société Européenne de Neurologie Pédiatrique (SENP+) is an international society made up of specialists in pediatric neurology, practicing in the south-western part of the European Community: France, Italy, Portugal, Belgium, Switzerland, Luxembourg and Spain.
Every year, the SENP+ organizes meetings reserved for members of the association and a few invited guests – mostly future candidate-members. At these meetings, participants discuss a series of predefined topics in collaboration with experts (members and non-members of the Society).
Since its creation, the SENP+ has played an active role in the development of pediatric neurology. All SENP+ members have been pioneers in the creation of pediatric neurology societies in their countries. The SENP+ is committed to providing warm, human-scale meetings that encourage exchanges between professionals and the development of caring collaborations for the benefit of young neuropediatricians in training.
Sharing our intermediate results at the Annual Meeting of the Société Européenne de Neurologie Pédiatrique (SENP) has invigorated our commitment to advancing research and innovation in pediatric health. We are dedicated to collaborating with experts and stakeholders to improve patient outcomes and have the test as fast as possible covered and available.
